Perioperative Use of Antibiotics in Intra-Abdominal Surgical Infections

被引:7
|
作者
Kambaroudis, Apostolos G. [1 ]
Papadopoulos, Savvas [1 ]
Christodoulidou, Michelle [1 ]
Gerasimidis, Thomas [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Surg Clin 5, Hippokratio Hosp, Hellas, Greece
关键词
PROSPECTIVE RANDOMIZED-TRIAL; ANTIINFECTIVE AGENTS; HIGH-RISK; GUIDELINES; EPIDEMIOLOGY; RESISTANCE;
D O I
10.1089/sur.2009.069
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: We created a questionnaire with the aim of evaluating surgeon compliance with the guidelines for antibiotic use in the perioperative period in intra-abdominal surgical infections. We discuss the problems emerging from non-adherence to these guidelines. Methods: In the questionnaire, we tried to correlate the type of intra-abdominal infection with: (1) Time of antibiotic administration commencement; (2) type of antibiotic(s) administered; (c) duration of antibiotic administration; and (4) modification of antibiotic type/duration of administration in the presence of factors increasing the risk of treatment failure. In order to collect and process the data more easily, the patients were divided into four groups Group A: Community patients with intra-abdominal surgical infections and simple contamination of the peritoneal cavity according to the Surgical Infection Society (SIS) guidelines; Group B: Community patients with an intra-abdominal surgical infection evolving to secondary peritonitis per SIS guidelines; Group C: Community patients with an intra-abdominal surgical infection with a high risk of surgical site infection; and Group D: Patients with recent hospitalization or nosocomial or postoperative intra-abdominal infection. Results: The questionnaire was sent to the directors of 43 surgical clinics in northern Greece, and 27 answered (63%). In 81.5% of the clinics (median 22; range 15-24), depending on the type of infection, empirical antibiotic treatment commenced preoperatively. In Group A, on average, 29.6% of the clinics (median 8; range 5-16) administer antibiotics for as long as 24h, and 11.1% (median 3; range 1-10) use antibiotics not recommended in the SIS guidelines (e.g., third- and fourth-generation cephalosporins, ciprofloxacin, imipenem-cilastatin, meropenem, or piperacillin/tazobactam). In Group B, 22.2% of clinics (median 6; range 2-15) administer antibiotics for three to five days, and 14.8% (median 4; range 1-1.1) use antibiotics outside SIS guidelines. In Group C, 40.7% of clinics (median 11; range 1-14) administer antibiotics for more than five days, and 14.8% (median 4; range 1-14) use antibiotics that are outside the SIS guidelines. In Group D, 11.1% of clinics (median 3; range 2-5) do not cover Enterococcus with the antibiotics administered. Conclusions: There seems to be confusion in determining the situations with simple contamination of the peritoneal cavity, whose treatment requires short-duration antibiotic administration, and in the type of antibiotics administered to various patient groups, elements that lead to prolonged or erroneous administration of antibiotic drugs. Continuous discussion and surgeon training is imperative and may be the best choice to ensure familiarity with antibiotics and their proper use and thus to minimize serious adverse events and treatment failure.
引用
收藏
页码:535 / 544
页数:10
相关论文
共 50 条
  • [1] Korean Guidelines for Use of Antibiotics for Intra-abdominal Infections in Adults
    Yoon, Young Kyung
    Moon, Chisook
    Kim, Jieun
    Heo, Sang Taek
    Lee, Mi Suk
    Lee, Shinwon
    Kwon, Ki-Tae
    Kim, Shin-Woo
    INFECTION AND CHEMOTHERAPY, 2022, 54 (04): : 812 - 853
  • [2] Antibiotics for prophylaxis and treatment of intra-abdominal infections
    Michalopoulos, A
    Geroulanos, S
    HEPATO-GASTROENTEROLOGY, 1997, 44 (16) : 947 - 958
  • [3] Source Control and Antibiotics in Intra-Abdominal Infections
    Bova, Raffaele
    Griggio, Giulia
    Vallicelli, Carlo
    Santandrea, Giorgia
    Coccolini, Federico
    Ansaloni, Luca
    Sartelli, Massimo
    Agnoletti, Vanni
    Bravi, Francesca
    Catena, Fausto
    ANTIBIOTICS-BASEL, 2024, 13 (08):
  • [4] New and Emerging Antibiotics for Complicated Intra-Abdominal Infections
    Durand, Cheryl R.
    Alsharhan, Mohammad
    Willett, Kristine C.
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (06) : e763 - e769
  • [5] Intra-abdominal infections: considerations for the use of the carbapenems
    Kioumis, Ioannis P.
    Kuti, Joseph L.
    Nicolau, David P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 167 - 182
  • [6] Intra-abdominal infections
    Marshall, JC
    MICROBES AND INFECTION, 2004, 6 (11) : 1015 - 1025
  • [7] Intra-abdominal Infections
    Shirah, Gina R.
    O'Neill, Patrick J.
    SURGICAL CLINICS OF NORTH AMERICA, 2014, 94 (06) : 1319 - +
  • [8] Intra-abdominal infections
    Pieracci, Fredric M.
    Barie, Philip S.
    CURRENT OPINION IN CRITICAL CARE, 2007, 13 (04) : 440 - 449
  • [9] Intra-abdominal infections
    Minton, J
    Stanley, P
    CLINICAL MEDICINE, 2004, 4 (06) : 519 - 523
  • [10] Intra-abdominal Infections
    Napolitano, Lena M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 43 (01) : 10 - 27